Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jensen‡, Peder K."'
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 17:156-164
Aim: A previous phase 2 study of patients undergoing non-urgent PCI treated with SCH530348 plus aspirin and clopidogrel tended to reduce MACE without increased bleeding. This study evaluated the safety of SCH530348 in Japanese patients with NSTE ACS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230d1dd6a47dbbbb1e3b0a8b411fe85d
https://doi.org/10.5551/jat.3038
https://doi.org/10.5551/jat.3038
Publikováno v:
Journal of Pharmacological Sciences, Vol 108, Iss 4, Pp 433-438 (2008)
Atherothrombotic disease is a leading public health problem. Although current antiplatelet agents, such as aspirin and adenosine diphosphate (ADP)-receptor antagonists, reduce the morbidity and mortality associated with atherothrombotic disease, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22fb2772603fa562fcef7142ce48b8c8
https://doi.org/10.1254/jphs.08r06fm
https://doi.org/10.1254/jphs.08r06fm
Autor:
Christopher Banfield, Margaret Salfi, Jensen Peder K, A. Richens, M.B. Affrime, Amin A. Nomeir, Paul Glue, Chin-Chung Lin
Publikováno v:
Scopus-Elsevier
Aims The objective of this study was to compare the pharmacokinetics, safety and tolerability of the antiepileptic drug felbamate in young and elderly healthy vounteers. Methods The single and multiple dose pharmacokinetics of felbamate were examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b32df15a236b15fd58f0c65311c7276
https://doi.org/10.1046/j.1365-2125.1997.00642.x
https://doi.org/10.1046/j.1365-2125.1997.00642.x
Autor:
Gordon Sussman, Jouko Suonpää, Michel A. Drouin, William H. Yang, Mattheus Roovers, Paul Van Cauwenberge, Peter Clement, Royce Darnell, Bernard Bertrand, K. Y. Tan, Keith B Nolop, Jacques Hébert, Jorge Mazza, Kjell Dalby, Göran Karlsson, Jensen Peder K, Thomas-Matthias Ernst, Pirkko Ruoppi, Martin A. Stern, Kam Tse, Michel Seppey, Barry N. Lutsky, George Luciuk, Prabowo Widjaja
Publikováno v:
Annals of Allergy, Asthma & Immunology. 77:153-160
Background: Perennial allergic rhinitis is chronic and persistent, may lead to a constellation of secondary complaints including sinusitis, mouth-breathing, and some symptoms resembling a permanent cold, and often requires constant medical interventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4de55d22c340a4f1e49fcbd5bd348d4
https://doi.org/10.1016/s1081-1206(10)63502-8
https://doi.org/10.1016/s1081-1206(10)63502-8
Autor:
Robert Schumaker, Christopher Banfield, J. Jen, James L. Perhach, Melton B. Affrime, Paul Glue, Jensen Peder K, Guang-Rui Zhu
Publikováno v:
Therapeutic Drug Monitoring. 18:19-29
The effects of age on felbamate apparent clearance were examined through a retrospective analysis of plasma concentration data from 700 pediatric and adult epileptic patients (age range, 2-74 years) enrolled in six clinical studies. Patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51688f22980841d0730d5229dad2e9a9
https://doi.org/10.1097/00007691-199602000-00004
https://doi.org/10.1097/00007691-199602000-00004
Autor:
Jensen Peder K
Publikováno v:
Epilepsia. 34:S25-S29
Felbamate (FBM) is a new antiepileptic drug (AED) that has been tested in open and controlled studies in patients with therapy-refractory partial-onset seizures. Proof of efficacy is based on results of five controlled studies (three with polytherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b140944858cc3125e0536668df73d2c2
https://doi.org/10.1111/j.1528-1157.1993.tb04591.x
https://doi.org/10.1111/j.1528-1157.1993.tb04591.x
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 21(4)
Vorapaxar, formerly SCH 530348, is a novel, orally active, potent thrombin receptor inhibitor selective for the protease-activated receptor-1 (PAR-1). Previous phase II studies of patients undergoing urgent or scheduled percutaneous coronary interven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d013d513860efc39d45943dfcbc74d
https://pubmed.ncbi.nlm.nih.gov/20947374
https://pubmed.ncbi.nlm.nih.gov/20947374
Autor:
Jeffrey W. Meehan, Amin A. Nomeir, Christopher Banfield, Melton B. Affrime, Jensen Peder K, Elaine Radwanski, Pertti Haring, Veijo Saano, Pascale Reidenberg, Paul Glue, Chin-Chung Lin, Robert D. Colucci
Publikováno v:
Clinical pharmacology and therapeutics. 58(5)
The effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive containing 30 micrograms ethinyl estradiol and 75 micrograms gestodene were assessed in a randomized, double-blind, placebo-controlled parallel-group study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6570aec72fd0a3a4633f7400c4d45c
https://pubmed.ncbi.nlm.nih.gov/7586946
https://pubmed.ncbi.nlm.nih.gov/7586946
Autor:
Jensen Peder K
Publikováno v:
Epilepsia. 35
Felbamate (FBM, Felbatol/Taloxa), a new antiepileptic drug (AED), was tested in a placebo-controlled add-on design in 73 patients with therapy refractory Lennox-Gastaut syndrome. Results of the efficacy analysis showed that FBM was statistically sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::852137de8adad5dd413616cc7b6b738b
https://pubmed.ncbi.nlm.nih.gov/8039473
https://pubmed.ncbi.nlm.nih.gov/8039473
Autor:
Jensen Peder K, G. R. Zhu, F. Jen, Christopher Banfield, D. Anbar, M.B. Affrime, P Glue, Samuel Heft
Publikováno v:
Neuropsychopharmacology. 11:270-270
The effect of age on plasma felbamate (F) clearance was examined through a retrospective analysis of concentration data from pediatric and adult epileptic patients in six clinical studies. Patients received F either as monotherapy (MONO), or in combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c830c693dc89c7bc53b0eb88c4e5403c
https://doi.org/10.1038/sj.npp.1380153
https://doi.org/10.1038/sj.npp.1380153